Abstract |
Bispecific antibodies have been exploited both as cancer immunodiagnostics and as cancer therapeutics, and have shown promise in several clinical trials in cancer imaging and therapy. A number of bispecific antibodies against B-cell markers have been shown to be effective in vitro in mediating tumor cell lysis and in vivo in inhibiting tumor growth in animal models. We have constructed a bispecific diabody from the variable genes encoding two hybridoma-derived monoclonal antibodies directed against human CD20 on B cells and CD3 on T cells. The anti-CD20 x anti-CD3 diabody was expressed in a single Escherichia coli host and purified by a one-step affinity chromatography. The bispecific diabody bound as efficiently to both CD20- and CD3-positive cells as the respective parental antibodies, and was capable of cross-linking CD20-positive tumor cells and human T lymphocytes as shown by cellular rosetting. The diabody effectively lysed human B- lymphoma cells in the presence of T-enriched human peripheral blood lymphocytes (PBL). Further, when combined with human PBL and interleukin-2, the diabody significantly prolonged the survival of nude mice inoculated with human B- lymphoma cells. Taken together, our results suggest that an anti-CD20 x anti-CD3 diabody may have significant clinical application in the treatment of human CD20-positive B-cell malignancies.
|
Authors | Dongsheng Xiong, Yuanfu Xu, Hanzhi Liu, Hui Peng, Xiaofeng Shao, Zenzu Lai, Dongmei Fan, Min Yang, Junling Han, Yong Xie, Chunzheng Yang, Zhenping Zhu |
Journal | Cancer letters
(Cancer Lett)
Vol. 177
Issue 1
Pg. 29-39
(Mar 08 2002)
ISSN: 0304-3835 [Print] Ireland |
PMID | 11809528
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Bispecific
- Antigens, CD20
- CD3 Complex
- Recombinant Proteins
|
Topics |
- Animals
- Antibodies, Bispecific
(therapeutic use)
- Antigens, CD20
(immunology)
- Binding Sites, Antibody
- CD3 Complex
(immunology)
- Cytotoxicity, Immunologic
- Female
- Flow Cytometry
- Genetic Vectors
- Humans
- Jurkat Cells
- Lymphoma, B-Cell
(immunology, therapy)
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Recombinant Proteins
(therapeutic use)
- Survival Rate
- Transplantation, Heterologous
|